HuagongsheHuagongshe Chemistry Print Report · For research reference only
3-(Bromomethyl)-4-methyl-1,2,5-oxadiazole → tert-Butyl-[7-(3,3-difluoro-pyrrolidin-1-yl)-2-(4-methyl-furazan-3-ylmethyl)-2H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl]-amine
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 3-(Bromomethyl)-4-methyl-1,2,5-oxadiazole | HCID 19832741 | — |
| Reactant | 5-tert-Butyl-7-(3,3-difluoro-pyrrolidin-1-yl)-2-ethyl-2H-[1,2,3]triazolo[4,5-d]pyrimidine | HCID 71576307 | — |
| Reactant | HCID 178448870 | HCID 178448870 | — |
| Product | tert-Butyl-[7-(3,3-difluoro-pyrrolidin-1-yl)-2-(4-methyl-furazan-3-ylmethyl)-2H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl]-amine | HCID 71576309 | — |
Reaction Steps
In analogy to the procedure described for the synthesis of 5-tert-butyl-7-(3,3-difluoro-pyrrolidin-1-yl)-2-ethyl-2H-[1,2,3]triazolo[4,5-d]pyrimidine (example 3, step b), the title compound was prepared from tert-Butyl-[7-(3,3-difluoro-pyrrolidin-1-yl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl]-amine and 3-(bromomethyl)-4-methyl-1,2,5-oxadiazole. MS (m/e): 394.4 (MH+)
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US09067943B2 |
| Source dataset | uspto-grants-2015_06 |
| ORD ID | ord-b6a559fd43a04387ad8415c22d641a00 |
| Source note | uspto-grants-2015_06 |